Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

[1]  R. Collins,et al.  Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab , 2000, Journal of the American College of Cardiology.

[2]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[3]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[4]  A. Cohen-Solal,et al.  Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. , 1998, Circulation.

[5]  H. Crijns,et al.  Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction. , 1998, The American journal of cardiology.

[6]  A. Adam,et al.  Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study. , 1997, American journal of physiology. Heart and circulatory physiology.

[7]  J. Kjekshus,et al.  Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1997, The American journal of cardiology.

[8]  C. Heesch,et al.  Converting enzyme inhibitors cause pressure-independent resetting of baroreflex control of sympathetic outflow. , 1996, The American journal of physiology.

[9]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[10]  L. Baur,et al.  Combining salicylate and enalapril in patients with coronary artery disease and heart failure. , 1995, British heart journal.

[11]  S. Yusuf,et al.  Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. , 1994, Circulation.

[12]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[13]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[14]  A. Struthers,et al.  Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function. , 1993, British journal of clinical pharmacology.

[15]  W. Rudolph,et al.  Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. , 1992, Journal of the American College of Cardiology.

[16]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[17]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[18]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[19]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[20]  R. Day,et al.  Nonsteroidal antiinflammatory drugs--differences and similarities. , 1991, The New England journal of medicine.

[21]  I. Zucker,et al.  Renal sympathetic nerve and hemodynamic responses to captopril in conscious dogs: role of prostaglandins. , 1989, The American journal of physiology.

[22]  M. Packer.  Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure , 1988, Circulation.

[23]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[24]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.

[25]  N. Hollenberg,et al.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. , 1980, The Journal of clinical investigation.

[26]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.